Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Florid Cutaneous Papillomatosis Treatment & Management

  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Dirk M Elston, MD  more...
 
Updated: Jun 24, 2016
 

Medical Care

Although follow-up evaluation has been limited in most reported cases of florid cutaneous papillomatosis (FCP), marked improvement of the cutaneous lesions was observed in 7 patients after they underwent surgical or chemotherapeutic treatment of the internal cancer. In at least 1 patient, local recurrence of the tumor was associated with a recurrence of florid cutaneous papillomatosis. In other cases, generalization of the cancer was associated with severe worsening of the cutaneous lesions.

To the author's knowledge, the palliative treatment of cutaneous papillomas has not produced any significant improvement, except in one patient in whom topical 5-fluorouracil was used. Such palliative treatments include systemic therapy with oral retinoids, radiation, or smallpox vaccination. Topical treatments with steroids, vitamin A acid, urea, salicylic acid, podophyllotoxin,[11] and liquid nitrogen have also been tried.

Next

Long-Term Monitoring

Monitor patients for any recurrence of florid cutaneous papillomatosis (FCP) (assuming that it regresses after tumor therapy) because the reappearance of florid cutaneous papillomatosis can indicate a new tumor.

Previous
 
Contributor Information and Disclosures
Author

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, Rutgers New Jersey Medical School; Visiting Professor, Rutgers University School of Public Affairs and Administration

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, New York Academy of Medicine, American Academy of Dermatology, American College of Physicians, Sigma Xi

Disclosure: Nothing to disclose.

Specialty Editor Board

David F Butler, MD Section Chief of Dermatology, Central Texas Veterans Healthcare System; Professor of Dermatology, Texas A&M University College of Medicine; Founding Chair, Department of Dermatology, Scott and White Clinic

David F Butler, MD is a member of the following medical societies: American Medical Association, Alpha Omega Alpha, Association of Military Dermatologists, American Academy of Dermatology, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Phi Beta Kappa

Disclosure: Nothing to disclose.

Jeffrey J Miller, MD Associate Professor of Dermatology, Pennsylvania State University College of Medicine; Staff Dermatologist, Pennsylvania State Milton S Hershey Medical Center

Jeffrey J Miller, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Society for Investigative Dermatology, Association of Professors of Dermatology, North American Hair Research Society

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Additional Contributors

Takeji Nishikawa, MD Emeritus Professor, Department of Dermatology, Keio University School of Medicine; Director, Samoncho Dermatology Clinic; Managing Director, The Waksman Foundation of Japan Inc

Disclosure: Nothing to disclose.

Acknowledgements

The assistance of Edmund Janniger is greatly appreciated.

References
  1. Schwartz RA. Florid cutaneous papillomatosis. Clin Dermatol. 1993 Jan-Mar. 11(1):89-91. [Medline].

  2. Janniger EJ, Schwartz RA. Florid cutaneous papillomatosis. J Surg Oncol. 2010 Nov 1. 102(6):709-12. [Medline].

  3. Pollitzer S. Unna PG, Morris M, Leloir H, Duhring LA, eds. International Atlas of Rare Skin Diseases. London, England: HK Lewis; 1891. 1-3.

  4. Yang YH, Zhang RZ, Kang DH, Zhu WY. Three paraneoplastic signs in the same patient with gastric adenocarcinoma. Dermatol Online J. 2013 Jul 14. 19(7):18966. [Medline].

  5. Schwartz RA, Burgess GH. Florid cutaneous papillomatosis. Arch Dermatol. 1978 Dec. 114(12):1803-6. [Medline].

  6. Stieler W, Plewig G. [Acanthosis nigricans maligna and Leser-Trelat sign in double malignancy of the breast and stomach]. Z Hautkr. 1987 Mar 1. 62(5):344-66. [Medline].

  7. Dingley ER, Marten RH. Adenocarcinoma of the ovary presenting as acanthosis nigricans. J Obstet Gynaecol Br Emp. 1957 Dec. 64(6):898-900. [Medline].

  8. Millard LG, Gould DJ. Hyperkeratosis of the palms and soles associated with internal malignancy and elevated levels of immunoreactive human growth hormone. Clin Exp Dermatol. 1976 Dec. 1(4):363-8. [Medline].

  9. Ellis DL, Kafka SP, Chow JC, et al. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med. 1987 Dec 17. 317(25):1582-7. [Medline].

  10. Singhi MK, Gupta LK, Bansal M, Jain V, Kachhawa D. Florid cutaneous papillomatosis with adenocarcinoma of stomach in a 35 year old male. Indian J Dermatol Venereol Leprol. 2005 May-Jun. 71(3):195-6. [Medline].

  11. Csete B, Moezzi M, Lengyel Z, Hodosi B, Zombai E, Battyani Z. Florid cutaneous papillomatosis leading to social exclusion. Br J Dermatol. 2005 Sep. 153(3):667-9. [Medline].

  12. Amano T, Nishida T, Inada M. Diffuse esophageal papillomatosis in a patient with acanthosis nigricans. Dig Endosc. 2016 May 10. [Medline].

  13. Brinca A, Cardoso JC, Brites MM, Tellechea O, Figueiredo A. Florid cutaneous papillomatosis and acanthosis nigricans maligna revealing gastric adenocarcinoma. An Bras Dermatol. 2011 Jun. 86(3):573-7. [Medline].

  14. Kleikamp S, Bohm M, Frosch P, Brinkmeier T. [Acanthosis nigricans, papillomatosis mucosae and "tripe palms" in a patient with metastasized gastric carcinoma]. Dtsch Med Wochenschr. 2006 May 26. 131(21):1209-13. [Medline].

  15. Bottoni U, Dianzani C, Pranteda G, et al. Florid cutaneous and mucosal papillomatosis with acanthosis nigricans revealing a primary lung cancer. J Eur Acad Dermatol Venereol. 2000 May. 14(3):205-8. [Medline].

  16. Jung DS, Oh CK, Lee JB, Kim MB, Jang HS, Kwon KS. Three Cases of Cutaneous Paraneoplastic Syndromes: Coexistence of Acanthosis Nigricans, Tripe Palms and Cutaneous Florid Papillomatosis. Korean J Dermatol. 2003. 41:1364-1369. [Full Text].

  17. Noh Y, Lee GC, Kim MK, Kim YS, Yoon TY. A Case of Florid Cutaneous Papillomatosis and Tripe Palm. Korean J Dermatol. 2002. 40:860-862. [Full Text].

  18. Stawczyk-Macieja M, Szczerkowska-Dobosz A, Nowicki R, Majewska H, Dubowik M, Sokolowska-Wojdylo M. Malignant acanthosis nigricans, florid cutaneous papillomatosis and tripe palms syndrome associated with gastric adenocarcinoma. Postepy Dermatol Alergol. 2014 Feb. 31(1):56-8. [Medline]. [Full Text].

  19. Vilas-Sueiro A, Suárez-Amor Ó, Monteagudo B, de Las Heras C. Malignant acanthosis nigricans, florid cutaneous and mucosal papillomatosis, and tripe palms in a man with gastric adenocarcinoma. Actas Dermosifiliogr. 2015 Jun. 106 (5):438-9. [Medline].

  20. Weger W, Ginter-Hanselmayer G, Hammer HF, Hodl S. Florid cutaneous papillomatosis with acanthosis nigricans in a patient with carcinomas of the lung and prostate. J Am Acad Dermatol. 2007 Nov. 57(5):907-8. [Medline].

  21. Yoo KH, Rho YK, Kim JY, Li K, Seo SJ, Hong CK. Cutaneous paraneoplastic syndrome in a patient with adenocarcinoma of unknown primary site syndrome. J Clin Oncol. 2009 Jan 10. 27(2):309-11. [Medline].

  22. Pentenero M, Carrozzo M, Pagano M, Gandolfo S. Oral acanthosis nigricans, tripe palms and sign of leser-trélat in a patient with gastric adenocarcinoma. Int J Dermatol. 2004 Jul. 43(7):530-2. [Medline].

  23. Tuveri M, Calò PG, Mocci C, Nicolosi A. Florid papillomatosis of the male nipple. Am J Surg. 2010 Apr 19. [Medline].

  24. Salemis NS. Florid papillomatosis of the nipple: A rare presentation and review of the literature. Breast Dis. 2015 Jun 1. 35 (2):153-6. [Medline].

  25. Grillo E, Miguel-Morrondo A, Vano-Galván S, Jaén-Olasolo P. [Oral florid papillomatosis]. Rev Clin Esp. 2012 Dec. 212(11):e93. [Medline].

  26. Jablonska S, Kozminska A, Chorzelski T. [An unusual variant of acanthosis nigricans. (Relations of acanthosis nigricans to generalized verrucosis)]. Dermatol Wochenschr. 1965 Feb 13. 151:177-85. [Medline].

  27. Nomachi K, Mori M, Matsuda N. Improvement of oral lesions associated with malignant acanthosis nigricans after treatment of lung cancer. Oral Surg Oral Med Oral Pathol. 1989 Jul. 68(1):74-9. [Medline].

  28. Nomura J, Tagawa T. Acanthosis nigricans with oral lesions and a malignant visceral tumor: a case report. J Oral Maxillofac Surg. 1992 Feb. 50(2):169-72. [Medline].

  29. Forman L. Acanthosis nigricans with discrete warts and marked mucous membrane changes in a patient with vitiligo. Proc Royal Soc Med. 1943. 36:611.

  30. Knapp A. [Pathogenesis of acanthosis nigricans.]. Dermatol Wochenschr. 1957 Mar 30. 135(13):313-27. [Medline].

  31. Milian G, Perin L, Babalian D. Condylomatose acuminee en nappe et acanthosis nigricans. Bull Soc Fr Dermatol Syoh. 1934. 41:1914-6.

  32. Schwartz RA. Acanthosis nigricans, florid cutaneous papillomatosis and the sign of Leser-Trèlat. Cutis. 1981 Sep. 28(3):319-22, 326-7, 330-1 passim. [Medline].

  33. Schwartz RA. Clinical Dermatology. 18th ed. New York, NY: Harper & Row; 1991. 1-3.

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.